| Aug 8 |
Geron Corporation Reports Second Quarter 2024 Financial Results and Business Highlights
|
| Aug 7 |
Geron Q2 2024 Earnings Preview
|
| Jul 31 |
Geron: Probabilistic And Modest Estimate Of Pricing For A Likely Acquisition
|
| Jul 26 |
Geron stock gains 6% on updated guidelines for Rytelo
|
| Jul 26 |
Geron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS
|
| Jul 24 |
Biggest stock movers today: TSLA, V, DB, T, and more
|
| Jul 24 |
Tesla Posts Weak Earnings, Joins Visa, Deutsche Bank And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
|
| Jul 24 |
Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board
|
| Jul 24 |
Geron stock dips as chief commercial officer departs
|
| Jul 23 |
Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024
|
